Influenza cases on the rise in Kerala; 19 deaths so far in 2025
Influenza is a seasonal disease caused by environmental and other factors, with fever and body pain being the common symptoms. However, a high proportion of elderly population and youngsters with lifestyle diseases, cancer, and obesity poses a threat.
According to Dr Rajeev Jayadevan, convenor of the Indian Medical Association (IMA) research cell, there are three strains of influenza viruses in circulation now. 'H1N1, H3N2 (both of which come in the Influenza A category), and Influenza B strains are circulating. Also, a vast majority of cases go undiagnosed as the symptoms are often indistinguishable from other common viral infections,' Dr Rajeev said.
The reason why fever and flu-related mortality is on the rise is the prevalence of comorbidities, pointed out Dr B Ekbal, a public health expert.
'Among the elderly and youngsters, more people are suffering from lifestyle diseases including diabetes, hypertension, and even cancer. In Kerala, only 40% of the people control diabetes properly. Obesity is also a major factor,' Dr Ekbal said.
The severity of the disease varies as per the patient profile. 'Those with comorbidities and among elderly, the condition can even cause death. If the host is weak, the impact will be greater,' Dr Rajeev said. Unlike Covid, influenza has effective treatment, and if symptoms are present, it is better to conduct a flu test, Dr Ekbal said. 'The number of people who undergo flu tests is low in the state. Antivirals, if taken within 48 hours, are effective too,' he said.
An expert panel led by Dr Ekbal — entrusted with formulating a new immunisation policy in November 2023 — had proposed a mandatory administration of flu jabs to those aged 65 and above, but no action has been taken.
The data on seasonal flu released by the National Centre for Disease Control revealed that Kerala reported the highest number of deaths due to influenza A till April 30 this year.
Precautions
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
All about the 'Nimbus' and 'Stratus', the new COVID variants monitored closely by WHO
COVID-19 might not dominate the headlines anymore, but that doesn't mean it has stopped evolving. In fact, behind the scenes, scientists are closely tracking several offshoots of the Omicron variant. Tired of too many ads? go ad free now Two of those, unofficially nicknamed Nimbus and Stratus, are now on the radar for their quick global spread and potential to evade immunity. Here's a closer look at what we know so far. Nimbus (NB.1.8.1) First spotted in early 2025, NB.1.8.1, or 'Nimbus', has made its presence felt quickly. It is currently listed as a 'variant under monitoring' (VUM) by the World Health Organization (WHO), - meaning they may require prioritised attention and tracking by health authorities due to their increased prevalence and potential public health implications. By late April, it had jumped from 2.5% to over 11% of all sequenced COVID-19 cases, especially across parts of Asia and the Western Pacific. Further, as per TODAY, 43% of cases in the U.S. are driven by this variant. Nimbus is part of the Omicron family, and it's a recombinant virus — a mash-up of different viral lineages that combined genetic material. It descends from a complex mix involving XDV, which itself was formed by blending JN.1 and another hybrid known as XDE. Symptoms of Nimbus According to the Global Alliance for Vaccines and Immunizations (Gavi), the symptoms of the NB.1.8.1 variant include: runny nose, headache, fatigue, sneezing, and sore throat. Additionally, people also might feel a razor blade sensation in the throat, which is the defining symptom for this variant, and gastrointestinal symptoms, including: nausea, vomiting, diarrhea, heartburn, bloating, constipation, and stomach pain. Tired of too many ads? go ad free now As of July 9, test positivity is at 3.1%, 0.1% higher than the previous week, according to the . The World Health Organization (WHO), in its May 23 evaluation, stated there's no current evidence that Nimbus is more dangerous than the other Omicron subvariants circulating today. Further, it also states that the currently approved COVID-19 vaccines are still expected to be effective against this variant. Stratus (XFG) First detected in Canada, Stratus (XFG) it's already made significant jumps into Europe and India. By late May, it was behind a quarter of new cases in parts of Europe, overtaking even Nimbus. Stratus, too, has been classified by the WHO as 'Variant under Monitoring'. Stratus is also a recombinant. It formed when two earlier variants, LF.7 and LP.8.1.2, crossed paths and exchanged genetic code. Like most of its Omicron cousins, it spreads quickly, prefers the upper respiratory tract, and seems less likely to lead to severe illness. According to the current available data, symptoms of XFG are similar to those of other Omicron sub-variants which are typically mild upper respiratory symptoms. Symptoms of the XFG People infected with the XFG subvariant have reported a range of symptoms including: chills, shortness of breath, sore throat, fatigue, headache, nausea, vomiting, muscle and body aches, diarrhea, and in some cases, a loss of taste or smell. What sets XFG slightly apart, according to early reports, is one more noticeable symptom: hoarseness. Several individuals have described a rough or raspy voice, which may serve as a subtle clue when trying to distinguish this variant from other circulating strains.
Time of India
2 hours ago
- Time of India
'My son diagnosed with autism and heart attack': Father's chilling testimony on mRNA COVID vaccine
The Senate Homeland Security Committee hears heartbreaking testimonies from victims of alleged mRNA COVID vaccine injuries. A Father, Brian Hooker, revealed his son suffered both a heart attack and was diagnosed with autism after vaccination. The hearing titled "Voices of the Vaccine-Injured" sheds light on stories mainstream media ignored. Watch explosive moments and emotional appeals to lawmakers. Show more Show less
Time of India
2 hours ago
- Time of India
Homeopathy doctors begin stir across state
Chhatrapati Sambhajinagar: Homeopathic doctors from across Maharashtra launched a state-level agitation on Wednesday, demanding registration with the Maharashtra Medical Council (MMC) for practitioners who have completed a bridge course. This comes after state govt reportedly put the registration process on hold due to objections from the Indian Medical Association (IMA). Dr Prakash Zambad, regional vice-president of the Homeopathy Integrated Medical Practitioners Association Maharashtra (HIMPAM), said that while a significant number of doctors staged a sit-in protest in Mumbai on Monday, over 90,000 homeopathic doctors statewide observed a day-long closure of their hospitals on Wednesday. "The necessary registration was scheduled to begin from July 15, but it is now put on hold by state govt for the next two months after the Indian Medical Association (IMA) objected to the move," Zambad said. He urged the government not to "succumb to the IMA pressure and resume the registration." The core of the dispute revolves around the Certificate Course in Modern Pharmacology (CCMP). According to the agitating doctors, the MMC had, via a notification dated June 30, declared this bridge course valid for homeopathic doctors to be registered with the allopathic medical council. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like American Investor Warren Buffett Recommends: 5 Books For Turning Your Life Around Blinkist: Warren Buffett's Reading List Support for the protesting homeopaths appears to be growing, with approximately 12 MLAs from various political parties reportedly visiting the protest site in Mumbai to express their solidarity. Opposing the notification, the IMA (Maharashtra) said such a "lateral entry" of homeopaths would dilute the medical field and pose a hazard to public health. After the IMA called for a strike on July 11, the govt formed a seven-member committee led by commissioner of medical education and ayush to arrive at the next decision.
